Sakmon, Rasil .

HRN: 20-19-11  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/10/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/10/2022
07/17/2022
IVT
570mg
Q8
Fracture Open Complete Displaced Oblique Tibia Fibula M3rd R
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  BloodstreamBone & JointSkin & Soft Tissue    Compliance to guidelines: Guideline Not Available

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: